Baudax Bio, Inc.
BXRXDelisted Feb 15, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001780097
Baudax Bio, Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Dec 19, 2022; 15 institutions reported holding it in 13F filings for Q3 2023, worth $74.5K in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Baudax Bio, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −12 vs. Q3 2022
- Shares held
- 23.0K
- −12.9K (−35.8%) vs. Q3 2022Converted for a 1-for-40 split
- Total value
- $73.2K
- −$278.8K (−79.2%) vs. Q3 2022
- New holders
- 1
- 3 more added
- Sold out
- 13
- 5 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 2 | $0 |
| Q3 2023 | 15 | $74.5K |
| Q2 2023 | 12 | $152.0K |
| Q1 2023 | 12 | $127.0K |
| Q4 2022 | 10 | $73.2K |
| Q3 2022 | 22 | $352.0K |
| Q2 2022 | 22 | $1.08M |
| Q1 2022 | 21 | $2.20M |
| Q4 2021 | 33 | $2.78M |
| Q3 2021 | 31 | $4.12M |
| Q2 2021 | 39 | $5.58M |
| Q1 2021 | 38 | $9.43M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Baudax Bio, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 18,802 | $59.8K | 0.00% | +18,802 | New |
| UBS Group AG | 3,011 | $9.57K | 0.00% | +1,077+55.7% | AddedConverted for a 1-for-40 split |
| BlackRock Inc. | 797 | $2.53K | 0.00% | 00.0% | UnchangedConverted for a 1-for-40 split |
| Tower Research Capital LLC (TRC) | 301 | $1.00K | 0.00% | +137+83.9% | AddedConverted for a 1-for-40 split |
| Edmond de Rothschild Holding S.A. | 71 | $226 | 0.00% | −0−0.6% | ReducedConverted for a 1-for-40 split |
| Group One Trading, L.P. | 4 | $13 | 0.00% | −1−24.9% | ReducedConverted for a 1-for-40 split |
| Wells Fargo & Company | 3 | $10 | 0.00% | +2+114.3% | AddedConverted for a 1-for-40 split |
| Morgan Stanley | 2 | $6 | 0.00% | −133−98.5% | ReducedConverted for a 1-for-40 split |
| Sittner & Nelson, LLC | 1 | $3 | 0.00% | −0−11.1% | ReducedConverted for a 1-for-40 split |
| Advisor Group Holdings, Inc. | 22 | $0 | 0.00% | −2−6.6% | ReducedConverted for a 1-for-40 split |
| Sabby Management, LLC | 0 | $0 | 0.00% | −10,981−100.0% | Sold outConverted for a 1-for-40 split |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −6,750−100.0% | Sold outConverted for a 1-for-40 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −6,038−100.0% | Sold outConverted for a 1-for-40 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −2,708−100.0% | Sold outConverted for a 1-for-40 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −1,639−100.0% | Sold outConverted for a 1-for-40 split |
| Vanguard Group Inc | 0 | $0 | 0.00% | −1,458−100.0% | Sold outConverted for a 1-for-40 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −1,213−100.0% | Sold outConverted for a 1-for-40 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,014−100.0% | Sold outConverted for a 1-for-40 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −648−100.0% | Sold outConverted for a 1-for-40 split |
| Dynamic Advisor Solutions LLC | 0 | $0 | 0.00% | −275−100.0% | Sold outConverted for a 1-for-40 split |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-40 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −15−100.0% | Sold outConverted for a 1-for-40 split |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-40 split |